Gene Signature Could Predict NSC Lung Cancer Response to Immunotherapy
New research has found genes that could help forecast how non-small cell lung cancer may respond to a treatment combination of low-dose radiation and immunotherapy. The researchers explained that these genes could help identify tumors that were more likely to be destroyed by immunotherapies. Immunotherapies work by activating an individual’s immune system to fight the cancer. Despite saving numerous lives, however, only about 25% of patients respond to it. Being able to predict who could benefit from this new discovery and the underlying mechanism of action would greatly benefit patients who gain no benefit from other modes of treatment. For…